1. Home
  2. GKOS vs FLR Comparison

GKOS vs FLR Comparison

Compare GKOS & FLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • FLR
  • Stock Information
  • Founded
  • GKOS 1998
  • FLR 1912
  • Country
  • GKOS United States
  • FLR United States
  • Employees
  • GKOS N/A
  • FLR N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • FLR Military/Government/Technical
  • Sector
  • GKOS Health Care
  • FLR Industrials
  • Exchange
  • GKOS Nasdaq
  • FLR Nasdaq
  • Market Cap
  • GKOS 5.8B
  • FLR 6.6B
  • IPO Year
  • GKOS 2015
  • FLR N/A
  • Fundamental
  • Price
  • GKOS $94.00
  • FLR $41.27
  • Analyst Decision
  • GKOS Strong Buy
  • FLR Buy
  • Analyst Count
  • GKOS 12
  • FLR 7
  • Target Price
  • GKOS $131.17
  • FLR $50.57
  • AVG Volume (30 Days)
  • GKOS 693.4K
  • FLR 4.1M
  • Earning Date
  • GKOS 11-03-2025
  • FLR 08-01-2025
  • Dividend Yield
  • GKOS N/A
  • FLR N/A
  • EPS Growth
  • GKOS N/A
  • FLR 970.51
  • EPS
  • GKOS N/A
  • FLR 24.07
  • Revenue
  • GKOS $432,953,000.00
  • FLR $16,313,000,000.00
  • Revenue This Year
  • GKOS $28.79
  • FLR $3.29
  • Revenue Next Year
  • GKOS $25.65
  • FLR $4.33
  • P/E Ratio
  • GKOS N/A
  • FLR $1.72
  • Revenue Growth
  • GKOS 26.70
  • FLR 3.61
  • 52 Week Low
  • GKOS $77.10
  • FLR $29.20
  • 52 Week High
  • GKOS $163.71
  • FLR $60.10
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 53.08
  • FLR 41.06
  • Support Level
  • GKOS $89.83
  • FLR $39.66
  • Resistance Level
  • GKOS $97.00
  • FLR $43.94
  • Average True Range (ATR)
  • GKOS 2.65
  • FLR 1.34
  • MACD
  • GKOS 0.39
  • FLR 0.37
  • Stochastic Oscillator
  • GKOS 71.27
  • FLR 41.82

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About FLR Fluor Corporation

Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services.It serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.

Share on Social Networks: